IQVIA™ Real-World Insights Bibliography

The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
Author(s): Lars Holger Ehlers 1, Mark Lamotte 2, Sofia Monteiro 3, Susanne Sandgaard 4, Pia Holmgaard 4, Evan C Frary 4, Niels Ejskjaer 5 6 7
Affiliations(s): 1Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 2IQVIA Real World Solutions, Zaventem, Belgium. 3IQVIA Real World Solutions, London, UK. 4Boehringer Ingelheim Danmark A/S, København Ø, Hovedstaden, Denmark. 5Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. n.ejskjaer@rn.dk. 6Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk. 7Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk.
Publication(s):  Diabetes Therapy https://doi.org/10.1007/s13300-021-01040-y
IQVIA HEOR Zaventem Brussels
PMID: 33856655 PMCID: PMC8099952 DOI: 10.1007/s13300-021-01040-y
Document Type(s): 
Countries: Denmark,
Click here for the abstract
C:
Y:
Diabetes, Health economics,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Author(s): Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9
Affiliations(s): 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 2IQVIA, Zaventem, Belgium. 3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com. 4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal. 5Department of Cardiology, Hospital de Braga, Braga, Portugal. 6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal. 7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 8Amgen SA, Portugal. 9Amgen (Europe) GmbH, Rotkreuz, Switzerland.
Publication(s):  PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019 IQVIA HEOR Zaventem Brussels
Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
Document Type(s): Article,
Countries: Portugal,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2021
  L:
A:
English
Burden of illness, Clinical setting: Primary care, Prospective study,
  Add to report
 
 
Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China
Author(s): Ahmed Salem 1, Peng Men 2 3, Mafalda Ramos 4, Yan-Jun Zhang 5, Anastasia Ustyugova 6, Mark Lamotte 7
Affiliations(s): 1IQVIA, Real World Solutions, Zaventem 1930, Belgium. 2Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China. 3Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China. 4IQVIA, Global HEOR, Porto Salvo 2740-266, Portugal. 5Boehringer Ingelheim, Health Economics & Outcomes Research, Government Affairs & Market Access, Shanghai 200040, China. 6Boehringer Ingelheim, CardioMetabolism Respiratory, Ingelheim am Rhein 55216, Germany. 7IQVIA, Global HEOR, Zaventem 1930, Belgium.
Publication(s):  Journal of Comparative Effectiveness Research 2021 https://doi.org/10.2217/cer-2020-0284.
PMID: 33576249 DOI: 10.2217/cer-2020-0284
Document Type(s): Article,
Countries: China,
Click here for the abstract
C:
Y:
Diabetes, Health economics,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium. 2R&D China, AstraZeneca R&D, Shanghai, China. 3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo. #Contributed equally.
Publication(s):  BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
Document Type(s): Article,
Countries: Belgium, China,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
A novel decision model to predict the impact of weight management interventions: The Core Obesity Model.
Author(s): Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4
Affiliations(s): 1Novo Nordisk A/S Søborg Denmark. 2IQVIA Zaventem Belgium. 3IQVIA Basel Switzerland. 4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK.
Publication(s):  Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495
Document Type(s): Article,
Countries: Belgium, Switzerland,
Click here for the abstract
C:
Y:
Health economics, Obesity,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
Author(s): Rui Cai 1, Laetitia Gerlier 2, Martin Eichner 3 4, Markus Schwehm 5, Sankarasubramanian Rajaram 6, Joaquin Mould-Quevedo 7, Mark Lamotte 2
Affiliations(s): 1IQVIA Real World Solutions, Amsterdam, The Netherlands. 2IQVIA (Global HEOR), Zaventem, Belgium. 3Epimos GmbH, Dusslingen, Germany. 4Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. 5ExploSYS GmbH, Leinfelden-Echterdingen, Germany. 6Seqirus Vaccines Ltd, Maidenhead, UK. 7Seqirus Vaccines, Summit, NJ, USA
Publication(s):  Journal of Medical Economics 2021. https://doi.org/10.1080/13696998.2021.1908000
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Immunology and Vaccination,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Type 2 diabetes and cancer: an umbrella review of observational and Mendelian randomisation studies
Author(s): Jonathan Pearson-Stuttard 1, Nikos Papadimitriou 2 3, Georgios Markozannes 2, Sofia Cividini 4, Artemisia Kakourou 2, Dipender Gill 5, Evangelos C Rizos 6 7, Grace Monori 5, Heather A Ward 5, Maria Kyrgiou 8 9, Marc J Gunter 3, Konstantinos K Tsilidis 2 5
Affiliations(s): 1Department of Epidemiology and Biostatistics, MRC-PHE Center for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom. j.pearson-stuttard@imperial.ac.uk. 2Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece. 3Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France. 4Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom. 5Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. 6Department of Internal Medicine, University Hospital of Ioannina, Ioannina, Greece. 7School of Medicine, European University of Cyprus, Nicosia, Cyprus. 8Department of Gut, Metabolism and Reproduction, and Surgery and Cancer, IRDB, Imperial College London, London, United Kingdom. 9West London Gynecological Cancer Center, Imperial NHS Trust, London, United Kingdom. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. IQVIA.
Publication(s):  PMID: 33737302 DOI: 10.1158/1055-9965.EPI-20-1245
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Diabetes,
2021
  L:
A:
English
Epidemiological study, Literature Review, Meta analysis,
  Add to report
 
 
Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients? data using machine learning - based on the ARCTIC study Respiratory Medicine
Author(s): Karin Lisspers a,*, Bj¨orn St¨allberg a, Kjell Larsson b, Christer Janson c, Mario Müller d, Mateusz Łuczko e, Bine Kjøller Bjerregaard f, Gerald Bacher g, Bj¨orn Holzhauer g, Pankaj Goyal g, Gunnar Johansson a
Affiliations(s): a Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden b Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden c Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden d IQVIA, Frankfurt am Main, Germany e IQVIA, Warsaw, Poland f IQVIA, Copenhagen, Denmark g Novartis Pharma AG, Basel, Switzerland
Publication(s): 
Document Type(s): 
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Predictive analytics,
  Add to report
 
 
Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Author(s): Colombo GL, Heiman F, Peduto I
Affiliations(s): Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publication(s):  Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Health economics, Overactive bladder,
2021
  L:
A:
English
Clinical setting: Primary care, Cost of illness,
  Add to report
 
 
Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
Author(s): P. Escribano (1), S. Gaine (2), P. Biedermann (3), A. Muller (3), M. Valge (4), T. Lange (5), S. Söderberg (6)
Affiliations(s): 1 Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain 2 National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland 3 Actelion Pharmaceuticals Ltd, Allschwil, Switzerland 4 StatFinn Estonia OÜ, Tartu, Estonia (now IQVIA) 5 University Medical Center Regensburg, Regensburg, Germany 6 Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden
Publication(s):  JO - The Journal of Heart and Lung Transplantation VL - 40 IS - 4, Supplement SP - S109 PY - 2021 DA - 2021/04/01/ SN - 1053-2498
Document Type(s): Abstract,
Countries: Canada, Europe,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
First Page Previous Page  2 of 413 Next Page Last Page